Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment (NCT02916810)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of the study is to test the hypothesis that functionally navigated repetitive TMS stimulations to the prefrontal cortex (PFC) modulate aberrant cortical electrical activities at PFC circuitry. The TMS location of the PFC site will be individually localized by the symptom-related functional connectivity between PFC and symptom related areas (such as the auditory and language processing cortex). The investigators predict that such modulation will correct abnormal activities in patients with schizophrenia, reduce symptoms, especially auditory hallucination, and improve working memory/sustained attention performance.
Who can join: Review the eligibility criteria below.
Location: The University of Texas Health Science Center at Houston — Houston, Texas
Age range: 18 Years to 50 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- The University of Texas Health Science Center at Houston — Houston, Texas
📞 Contact the Study Coordinator
Phone: (713) 486-2700
Email: Xiaoming.Du@uth.tmc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Schizophrenia and Related Disorders
- Social Isolation and Aging in Schizophrenia — Hartford, Connecticut
- SPARK Healthy Sleep — Indianapolis, Indiana
- MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction — New Haven, Connecticut
- "Extended" (Alternate Day) Antipsychotic Dosing — Toronto, Ontario
- Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia — Houston, Texas
Explore by condition: All Schizophrenia and Related Disorders clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.